BioMarin Pharmaceutical Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $828.0M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $19.0M | 2.3% |
| Other Investing | $57.4M | 6.9% |
| Other Financing | $42.4M | 5.1% |
| Other | $340.3M | 41.1% |
| Net Cash Flow | $368.8M | 44.5% |